Literature DB >> 32504267

Side-to-side duodenojejunostomy after resection of third and fourth duodenal portions with pancreatic preservation.

Gerardo Blanco-Fernández1, Adela Rojas-Holguín1, Noelia De-Armas-Conde1, Isabel Gallarín-Salamanca1, Diego López-Guerra2, Isabel Jaén-Torrejimeno1.   

Abstract

Infra-ampullary duodenal lesions are rare and surgical management is controversial. Reconstruction after resection is usually performed by end-to-end or end-to-side duodenojejunostomy. The goal was to analyze our experience, perioperative management, and results after side-to-side duodenojejunostomy. Therefore, we retrospectively evaluated short- and long-term results of surgical resections of third and fourth duodenal portions for several kinds of lesions and reconstruction through duodenojejunostomy performed in our facilities between January 2012 and December 2018. In total, 12 patients were selected for our study, six were male. The median age was 66.3 (IQR: 77.3-59.4). Lesion classification was as follows: 6 cases (50%) of duodenal adenocarcinoma, 4 cases (33.3%) of gastrointestinal stromal tumors (GISTs), and 2 cases (16.7%) of benign pathology. The most frequent clinical presentation was obstruction with vomiting. The surgical technique of choice was resection of third and fourth duodenal portions with a segment of proximal jejunum. Digestive continuity was restored through side-to-side duodenojejunostomy in 11 cases (91.6%). The median operation time was 182.5 min (IQR 237.5-136.3 min). Nine of the 12 patients (75%) did not receive intra- or postoperative blood transfusions. Six patients (50%) experienced complications during post-op. Four of them (33%) experienced major complications (Clavien-Dindo > IIIa) and three required re-op. The median follow-up was 58.3 (95% CI 15-101.5) months. Of the 11 patients with long-term follow-up, 10 have remained asymptomatic during follow-up. The average disease-free survival (DFS) was 43.1 months for adenocarcinoma, and 93 months for GIST. Based on the results of our series, although small, pancreas-sparing duodenectomy could be considered a feasible and safe technique with adequate oncological results. Side-to-side duodenojejunostomy appears to be a safe technique, is easy to perform, and has good functional outcomes. More studies with a larger number of patients are necessary to confirm these findings.

Entities:  

Keywords:  Duodenal neoplasm; Duodenal resection; Duodenojejunostomy; Postoperative morbidity

Mesh:

Year:  2020        PMID: 32504267     DOI: 10.1007/s13304-020-00823-5

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  21 in total

1.  A technique for the exposure of the third and fourth portions of the duodenum.

Authors:  R B CATTELL; J W BRAASCH
Journal:  Surg Gynecol Obstet       Date:  1960-09

2.  Segmental duodenal resection: indications, surgical techniques and postoperative outcomes.

Authors:  D Dorcaratto; H M Heneghan; B Fiore; F Awan; D Maguire; J Geoghegan; K Conlon; E Hoti
Journal:  J Gastrointest Surg       Date:  2015-01-17       Impact factor: 3.452

3.  Heparin-induced thrombocytopenia with hematoma necrosis and persistent high fever after gastric cancer surgery: A case report.

Authors:  Weihang Wu; Mingwei Wang; Weikang Zhou; Yu Wang
Journal:  Asian J Surg       Date:  2019-12-06       Impact factor: 2.767

4.  Surgical approach for tumours of the third and fourth part of the duodenum. Distal pancreas-sparing duodenectomy.

Authors:  Francisco J García-Molina; Francisco Mateo-Vallejo; Juan de Dios Franco-Osorio; Juan L Esteban-Ramos; Iosvany Rivero-Henández
Journal:  Int J Surg       Date:  2015-04-24       Impact factor: 6.071

5.  The PROCESS 2018 statement: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) guidelines.

Authors:  Riaz A Agha; Mimi R Borrelli; Reem Farwana; Kiron Koshy; Alexander J Fowler; Dennis P Orgill
Journal:  Int J Surg       Date:  2018-10-22       Impact factor: 6.071

6.  Feasibility and oncological outcomes of limited duodenal resection in patients with primary nonmetastatic duodenal GIST.

Authors:  Ahmed El-Gendi; Saba El-Gendi; Mohamed El-Gendi
Journal:  J Gastrointest Surg       Date:  2012-09-25       Impact factor: 3.452

7.  Adenocarcinoma of the third and fourth portions of the duodenum: results of surgical treatment.

Authors:  Adriano Tocchi; Gianluca Mazzoni; Francesco Puma; Michelangelo Miccini; Diletta Cassini; Elia Bettelli; Sandro Tagliacozzo
Journal:  Arch Surg       Date:  2003-01

8.  Limited resection for duodenal gastrointestinal stromal tumors: Surgical management and clinical outcome.

Authors:  Jens Hoeppner; Birte Kulemann; Goran Marjanovic; Peter Bronsert; Ulrich Theodor Hopt
Journal:  World J Gastrointest Surg       Date:  2013-02-27

9.  Pancreas-sparing distal duodenectomy for infrapapillary neoplasms.

Authors:  D R C Spalding; A M Isla; J N Thompson; R C N Williamson
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

10.  Pancreaticoduodenectomy versus limited resection for duodenal gastrointestinal stromal tumors: a systematic review and meta-analysis.

Authors:  Zefeng Shen; Ping Chen; Nannan Du; Parishit A Khadaroo; Danyi Mao; Lihu Gu
Journal:  BMC Surg       Date:  2019-08-28       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.